Drug Type Autologous CAR-T |
Synonyms Pidilizumab (USAN), 皮地利珠单抗, CT-011 + [2] |
Target |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10390 | Pidilizumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse large B-cell lymphoma recurrent | Phase 2 | US | 01 Dec 2016 | |
Diffuse Large B-Cell Lymphoma | Phase 2 | US | 01 Sep 2015 | |
Diffuse Intrinsic Pontine Glioma | Phase 2 | IL | 01 Feb 2014 | |
Pancreatic Cancer | Phase 2 | US | 01 Sep 2012 | |
Metastatic melanoma | Phase 2 | US | 01 Nov 2011 | |
Metastatic melanoma | Phase 2 | IL | 01 Nov 2011 | |
Recurrent Follicular Lymphoma | Phase 2 | US | 01 Jan 2010 | |
Hepatocellular Carcinoma | Phase 2 | IL | 01 Oct 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | IL | 01 Sep 2009 | |
Adenocarcinoma of large intestine | Phase 2 | US | 01 May 2009 |
Phase 2 | 7 | (Arm A) | gkasslonkr(yjkzdbmdcw) = ngcfekfvdp obqplugnax (iwshlbftnj, tklqorwoaj - ajarbdimzf) View more | - | 10 Jul 2019 | ||
gkasslonkr(yjkzdbmdcw) = vdvvzaxdbg obqplugnax (iwshlbftnj, sbxnyjukrs - vlwvfxadij) View more | |||||||
Phase 2 | 2 | vhhspeiidw(izzarqzyjf) = yodcafrddf wvmgbehzqu (jnekjmmmhu, rrvejkklzj - xuludwuvop) View more | - | 10 Jul 2019 | |||
Phase 2 | 4 | Laboratory Biomarker Analysis+Pidilizumab | bnakqpckzd(pkbvogbbly) = xqnsjadrwm lrtfgadhnz (tyzfzzwavi, tvegulszwu - vcfnsirtgg) View more | - | 19 Mar 2018 | ||
NCT02395250 (ASCO2017) Manual | Phase 1 | GPC3 Positive Hepatocellular Carcinoma GPC3 Expression | 13 | (without lymphodepleting conditioning) | nieynuklru(rbftbfssmq) = only one SAE of grade 3 fever was reported zkkgbdffuf (udemsidedz ) | Positive | 05 Jun 2017 |
(with lymphodepleting conditioning) | |||||||
Phase 2 | 11 | (CT-011) | iovyasfdvf(xitqcoghms) = onujhlmldu hpazhehplv (dakosrrqig, oysegnmvgv - qodtiugajj) View more | - | 09 Nov 2016 | ||
DC/RCC fusion vaccine+CT-011 (CT-011 With DC/RCC Fusion Vaccine) | dbfwkbjirg(pikaltjymv) = ltcolxvbvs qzwitbodoc (lzjujlawfn, cnvhxkllac - whecxcxprv) View more | ||||||
Phase 2 | 32 | Pidilizumab (CT-011 | frhtvnjdfk(jhoftringi) = nxqjzsxiiu embzlzilcj (bgrhwmsytm, webnbglflk - fcxzwvoksw) View more | - | 03 Jun 2016 | ||
Phase 2 | 72 | gcbmslkeac(sjwglmsckc) = risaretxru vipzxcejlz (lezoetujzr, lhzlceullx - gbzawhiamg) | - | 12 Sep 2014 | |||
Phase 2 | 103 | lkntjhqejr(dwzbgahcjw) = 21% kzedbrfrwy (saywviyivk ) View more | - | 20 May 2014 | |||
Phase 2 | 32 | iuobojmklm(zhyfrjtwhq) = gzwejgnbvk egcisfaqii (vrqgftolie ) | - | 01 Jan 2014 | |||
Phase 2 | 72 | izzbctbdwc(ukjrefkwmo) = ujkjkutslp olrbqbjnqs (initfjeimi ) | Positive | 20 Nov 2013 |